Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Kinetic Control Versus Dynamic Taping on First Metatarsophalangeal Joint in Athletes With Functional Hallux Limitus

2 de julio de 2026 actualizado por: Fatemah M. Alboraei, Cairo University

Kinetic Control Versus Dynamic Taping on First Metatarsophalangeal Joint Performance and Injury Prevention in Athletes With Functional Hallux Limitus: A Randomized Controlled Trial

This study is conducted to investigate and compare the effect of adding either kinetic control retraining or dynamic taping to the standard treatment program on first metatarsophalangeal joint dorsiflexion active range of motion, first metatarsophalangeal joint dorsiflexion strength, forefoot strike pattern running, vertical jump performance, and lower limb injury prevention in intermediate-professional level indoor sports athletes with functional hallux limitus.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Descripción detallada

this study will be conducted, using valid and reliable methods and instrumentations, to evaluate and compare the effect of adding either kinetic control retraining or dynamic taping to the standard treatment program on first metatarsophalangeal joint dorsiflexion active range of motion, first metatarsophalangeal joint dorsiflexion strength, forefoot strike pattern running, vertical jump performance and lower limb injury prevention in indoor sports athletes with functional hallux limitus. This may add a new hope to decrease the rate of injuries occurrence or recurrence which will diminish financial expenses and lengthen athletes' competitiveness time in courts.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

90

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Fatemah Mahmoud Alboraei, master degree
  • Número de teléfono: 00201010330474 00201550801318
  • Correo electrónico: fatemah.alboraei@gmail.com

Ubicaciones de estudio

    • Zahraa Almaady
      • Cairo, Zahraa Almaady, Egipto
        • Reclutamiento
        • Fatemah M. Alboraei
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Ninety male and female indoor sports' athletes at intermediate to professional level of indoor sports.
  • Athletes aged from 18 to 35 years.
  • Body Mass Index ranged from 22.5- 28 kg/cm2.
  • Athletes with a habitual Fore Foot Strike Pattern by determining foot strike angle using Insole Pressure Sensors.
  • Athletes with less than 37° of the first metatarsophalangeal joint dorsiflexion active range of motion using a Digital Goniometer (Positive Jack test).
  • Athletes with less than 50° of the first metatarsophalangeal joint dorsiflexion active range of motion using a Digital Goniometer. (Positive flexor hallucis longus stretch text).
  • Athletes with at least a 1.8-kg (4-lb) difference in first metatarsophalangeal joint dorsiflexion strength as compared to the opposite side using hand-held dynamometer.
  • Athletes with pinch calluses, hyperkeratotic skin lesions identified by palpation on the medial surface of the affected first metatarsophalangeal joint (not the metatarsal head).
  • Athlete's shoes must be with a minimal or no heel to toe drop design to facilitate Fore Foot Strike Pattern as Foot Strike Patterns may be facilitated partly by the shoe wear type.
  • If any athlete changes the running shoes, it must be a safe transition for a few weeks to few months, to avoid injuries (stress fractures) or performance alteration.

Exclusion Criteria:

  • Athletes with other habitual foot strike patterns rather than a forefoot strike pattern.
  • Any limitation to the first metatarsophalangeal joint dorsiflexion active range of motion while resting plantar flexion position of the ankle.
  • Athletes shoes that are cushioned with a high heel-to-toe drop which encourages Rearfoot Strike Pattern as foot strike patterns may be facilitated partly by the type of shoe wear.
  • History of musculoskeletal system disorders (spine deformities, disc pathologies, orthopedic contractures, or osseous deformities such as: Sheperds fracture, Large steidas process, Ostrigonum Cysts and dorsal talar exostosis.
  • History of surgeries in the last six months.
  • History of neurological disorders.
  • Any preexisting injury that may become exacerbated or made worse with participation.
  • History of contact dermatitis or cutaneous adverse reaction to Dynamic Tape.
  • Radiological signs as first metatarsophalangeal joint head alterations, dorsal or lateral spurs, and bunion formation, as mostly radiographs of Functional Hallux Limitus are normal and these signs are more relevant to hallux rigidus which will not be evaluated in this study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: standard treatment program
Thirty male & female athletes will receive the standard treatment program of Functional Hallux Limitus.
The text details therapeutic techniques for managing first metatarsophalangeal joint (1stMTPJ) issues, including: 1) First MTPJ Manipulation with Grade IV mobilization and thrusts; 2) Subtalar Manipulation to improve mobility; 3) 1stMTPJ Mobilization through Grade III dorsal glides; 4) Sesamoid Mobilization involving rhythmic oscillations; 5) Strengthening Exercises conducted three times daily to enhance stability; 6) Flexibility Exercises for related muscle groups; and 7) Sham Taping to simulate dynamic taping effects.
Experimental: standard treatment program and kinetic control
Thirty male & female athletes will receive kinetic control retraining added to the standard treatment program of Functional Hallux Limitus.
The text details therapeutic techniques for managing first metatarsophalangeal joint (1stMTPJ) issues, including: 1) First MTPJ Manipulation with Grade IV mobilization and thrusts; 2) Subtalar Manipulation to improve mobility; 3) 1stMTPJ Mobilization through Grade III dorsal glides; 4) Sesamoid Mobilization involving rhythmic oscillations; 5) Strengthening Exercises conducted three times daily to enhance stability; 6) Flexibility Exercises for related muscle groups; and 7) Sham Taping to simulate dynamic taping effects.
kinetic control retraining emphasizes achieving ideal lower limb (LL) sagittal alignment to activate the kinetic chain from hip to foot. Key exercises include maintaining correct femur alignment, controlling knee movement, and focusing on eccentric control of various muscle groups. Specific routines target hip (glutes), knee (popliteus), and ankle/foot levels (tibialis posterior, anterior, soleus, peroneus brevis) to enhance stability and extensibility. Mobilization strategies address extensibility of gastrocnemius, peroneus longus, and toe flexors, ensuring functional alignment and proper loading techniques during exercises.
Experimental: standard treatment program and dynamic taping
Thirty male & female athletes will receive dynamic taping retraining added to the standard treatment program of Functional Hallux Limitus.
The text details therapeutic techniques for managing first metatarsophalangeal joint (1stMTPJ) issues, including: 1) First MTPJ Manipulation with Grade IV mobilization and thrusts; 2) Subtalar Manipulation to improve mobility; 3) 1stMTPJ Mobilization through Grade III dorsal glides; 4) Sesamoid Mobilization involving rhythmic oscillations; 5) Strengthening Exercises conducted three times daily to enhance stability; 6) Flexibility Exercises for related muscle groups; and 7) Sham Taping to simulate dynamic taping effects.
Athletes will receive a briefing on the taping procedure before it starts, with the option for private administration. The functional correction technique is to be applied to limit first metatarsophalangeal joint plantar flexion. This involves measuring and applying an I-shaped strip of tape from the plantar surface over the toenail to the first metatarsophalangeal joint, ensuring no tension at the joint's base. The athlete's toe should be positioned in maximum plantar flexion while severe tension (150-200%) is applied, followed by laying down a J strip on the dorsum of the joint. The remaining tape should be placed with no tension, approximately one inch below the first metatarsophalangeal joint.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Assessment of active range of motion of the First metatarsophalangeal joint dorsiflexion
Periodo de tiempo: (pre-intervention) and after 4 weeks (post-intervention)
A digital goniometer will be utilized to measure the first metatarsophalangeal joint dorsiflexion same positions and will be marked in 1° increments. For the first metatarsophalangeal joint dorsiflexion measurements, a pen will be used to draw lines bisecting the first metatarsophalangeal joint and hallux and to mark the estimated metatarsophalangeal joint center.
(pre-intervention) and after 4 weeks (post-intervention)
Assessment of muscle strength of the First metatarsophalangeal joint dorsiflexion
Periodo de tiempo: (pre-intervention) and after 4 weeks (post-intervention)
Toe dynamometry is an objective tool used to measure toe flexor strength. The 'make' technique was used in all studies whereby the dynamometer is held stationary by a physical therapist or an external attachment and the athlete maximally push down onto the dynamometer with his First metatarsophalangeal joint
(pre-intervention) and after 4 weeks (post-intervention)
Forefoot running (step length, speed and propulsion rate)
Periodo de tiempo: (pre-intervention) and after 4 weeks (post-intervention)
therapist will place the Digitsole Pro system of intelligent pressure sensors and Digitsole pods in athletes' shoes to export data while running for 5 minutes after a sufficient warm-up for eight minutes of jogging. A compiled running performance data analysis of step length, speed, and propulsion rate will show in the form of dashboards through the Digitsole Pro® applications on an external tablet or mobile device.
(pre-intervention) and after 4 weeks (post-intervention)
Vertical jumping performance (flight time, vertical jump height, and takeoff velocity)
Periodo de tiempo: (pre-intervention) and after 4 weeks (post-intervention)
PT will Place the Digitsole Pro system of ntelligent pressure sensors and Digitsole pods in athletes' shoes to export data while dynamic vertical jumb for 5 minutes after a sufficient warm up for eight minutes of jogging. A compiled vertical jumb performance data analysis of flight time, vertical jump height and tack-off velocity will show in the form of dashboards through the Digitsole Pro® applications on an external tablet or mobile device.
(pre-intervention) and after 4 weeks (post-intervention)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

25 de marzo de 2026

Finalización primaria (Estimado)

30 de agosto de 2026

Finalización del estudio (Estimado)

30 de septiembre de 2026

Fechas de registro del estudio

Enviado por primera vez

6 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

2 de julio de 2026

Publicado por primera vez (Actual)

9 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir